ARDENT HEALTH INC
ARDTNYSETrading Snapshot
- Day Range
- $900.05 – $922.42
- 52-Week Range
- $7.71 – $15.48
- Volume
- $3.28B
- Avg Volume
- $3.09B
- Shares Outstanding
- 143.4M
- Next Earnings
- Nov 24, 2026
Fundamentals Snapshot
- Annual Revenue
- $6.32B
- Last Q Revenue
- $1.62B
- P/E Ratio
- 18.8
- P/S Ratio
- 0.2x
- EPS (TTM)
- $0.55
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +6.6%
Why Investors Own ARDT
- ✓High-growth profile — revenue up +22.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 30% gross margin and 24% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ARDENT HEALTH INC
ARDT
StockOtter · stockotter.spaceAbout ARDENT HEALTH INC
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
ARDENT HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ARDT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ARDENT HEALTH INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.